Trader Gunvor Buys Second Petroplus Oil Plant

Swiss-based trader Gunvor, co-owned by a Russian tycoon, has bought a second European oil plant from Petroplus, as trading houses emerge as the biggest winners from the insolvent refiner's asset sale.

Petroplus' five plants came on the market at a time when trading houses, traditionally the middle-men in global oil markets, are seeking to snap up physical assets to become more like integrated oil firms as profit margins shrink.

Gunvor's purchase of the 100,000 barrel per day Ingolstadt plant in Germany, announced on Thursday, follows an agreement to buy the Antwerp refinery in Belgium in March.

"...We are delighted to have signed a purchase agreement for what will be again a key asset for Gunvor as we look to confirm our presence in Europe and diversify our trading activity in Germany," said Gunvor Chief Executive Torbjorn Tornqvist.

Gunvor said it expected to complete the purchase in the third quarter and will restart the plant as soon as possible after a three-month outage.

The expansion of traders and private investors into the European downstream market comes as majors like Total and Royal Dutch Shell seek to exit the sector suffering from thin crude oil processing margins, often by selling plants at knock-down prices.

Earlier this month rival trading house Vitol teamed up with the co-founder of Petroplus, Marcel Van Poecke, to buy the insolvent refiner's Swiss plant.

The German plant's sale will likely come as a relief to authorities after the administrator for the Petroplus Coryton plant in Britain, widely seen as the firm's most attractive asset, failed to find a buyer, endangering hundreds of jobs.

Petroplus filed for insolvency in January after it defaulted on $1.75 billion of debt.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

most read

Photo
24.01.2025 • News

And the Winners are: Cynio, EnaDyne and Green Li-ion

The CHEManager Innovation Pitch, the start-up promotion initiative of CHEManager and CHEManager International, has given more than 100 start-ups from over 15 countries the opportunity to present their innovative ideas, products and technologies to a broad target group since its launch in 2019.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.